Epidemiologic appraisal of hypertension as a coronary risk factor in the elderly

Christopher J O'Donnell1, William B Kannel

  • 1National Heart, Lung, and Blood Institute's Framingham Heart Study, MA 01701, USA. chris@fram.nhlbi.nih.gov

Insights

Elevated blood pressure is a key risk factor for cardiovascular disease in older adults. Comprehensive risk assessment, including clustering of factors, is crucial for effective hypertension management and reducing coronary heart disease events.

Area of Science:

  • Cardiology
  • Geriatrics
  • Epidemiology

Background:

  • Elevated blood pressure is a significant risk factor for atherosclerotic cardiovascular diseases in the elderly.
  • Historically, hypertension management focused on diastolic blood pressure, but current research highlights systolic blood pressure and pulse pressure importance.

Purpose of the Study:

  • To emphasize the role of systolic blood pressure and risk factor clustering in cardiovascular disease among the elderly.
  • To advocate for multivariate risk assessment in managing hypertension in older adults.

Main Methods:

  • Review of epidemiologic research on blood pressure and cardiovascular disease in the elderly.
  • Analysis of risk factor clustering, including glucose intolerance, obesity, dyslipidemia, and their association with insulin resistance.
  • Evaluation of other contributing factors like elevated heart rate, fibrinogen, and left ventricular hypertrophy.

Main Results:

  • Systolic blood pressure, pulse pressure, and even high-normal blood pressure levels significantly influence coronary heart disease risk.
  • Risk of coronary heart disease increases with the clustering of risk factors, particularly in hypertensive individuals.
  • About 39% of coronary events in men and 68% in women are linked to two or more additional risk factors alongside hypertension.

Conclusions:

  • Hypertension in the elderly often coexists with other risk factors, necessitating screening for comorbid conditions and subclinical vascular disease.
  • Multivariate risk assessment profiles are superior to solely relying on blood pressure levels for targeting antihypertensive therapy in the elderly.
  • Therapeutic goals should encompass improving the overall multivariate risk profile and blood pressure levels.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...